BASEL, Switzerland, June 26 -- Liver Cancer, a peer-reviewed journal that says it focuses on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy of the disease, published research articles on the following topics in its June 2024 edition (Vol. 13, Issue 3):

Meta-Analysis:

* Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Revi . . .

Click here for more information about our products